Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Stella (Pavia, Italy), M. Bosio (Pavia, Italy), E. Salvaterra (Pavia, Italy), P. Morbini (Pavia, Italy), M. Zorzetto (Pavia, Italy), S. Inghilleri (Pavia, Italy), S. Tomaselli (Pavia, Italy), P. Mangiarotti (Pavia, Italy), F. Datturi (Pavia, Italy), F. Meloni (Pavia, Italy), I. Cerveri (Pavia, Italy). 5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin. 2859

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Prognostic value of promoter hypermethylation of tumor suppressor genes in malignant pleural fluid Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Alteration of p53 and FHIT genes in pleural effusion associated with malignancy Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002 Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 BAP1 expression and treatment outcomes in malignant mesothelioma. Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 Microsatellite alterations and cell free DNA analysis in malignant pleural effusion Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Detection of aberrant methylation of p16(INK4a) and MGMT in endobronchial specimens increases the diagnostic yield in cases of suspected peripheral lung carcinomas Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002 Gene expression mapping to diagnose malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002 Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Comparison of telomerase activity in malignant and benign pleural effusions Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathological characteristics of primary non small cell lung carcinoma Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012